|
protein dna complex disassembly
|
GO:0032986 |
1 |
1.000
|
Human |
|
nucleosome disassembly
|
GO:0006337 |
1 |
1.000
|
Human |
|
chromatin disassembly
|
GO:0031498 |
1 |
1.000
|
Human |
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.437
|
Human |
|
chromatin modification
|
GO:0016568 |
187 |
0.434
|
Human |
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.393
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.390
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.338
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.329
|
Human |
|
oligosaccharide catabolic process
|
GO:0009313 |
2 |
0.309
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.274
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.251
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.241
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.233
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.205
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.197
|
Human |
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.183
|
|
|
single species biofilm formation
|
GO:0044010 |
1 |
0.183
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.158
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.147
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.137
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.137
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.133
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.125
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.120
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.118
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.118
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.115
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.114
|
|
|
biofilm formation
|
GO:0042710 |
1 |
0.102
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.101
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.100
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.098
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.097
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.096
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.094
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.093
|
|
|
hatching
|
GO:0035188 |
4 |
0.089
|
|
|
chromatin remodeling at centromere
|
GO:0031055 |
2 |
0.085
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.085
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.083
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.083
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.081
|
Human |
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.081
|
|
|
histone modification
|
GO:0016570 |
159 |
0.081
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.080
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.080
|
|
|
dna methylation on cytosine
|
GO:0032776 |
5 |
0.079
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.078
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.078
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.078
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.077
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.076
|
Worm |
|
viral gene expression
|
GO:0019080 |
3 |
0.075
|
Human |
|
neural retina development
|
GO:0003407 |
41 |
0.074
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.073
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.073
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.072
|
Fly |
|
oligosaccharide metabolic process
|
GO:0009311 |
11 |
0.072
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.070
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.069
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.068
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.068
|
|
|
dna repair
|
GO:0006281 |
107 |
0.067
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.066
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.066
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.065
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.064
|
|
|
negative regulation of androgen receptor signaling pathway
|
GO:0060766 |
3 |
0.063
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.063
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.062
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.062
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.062
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.058
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.058
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.058
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.058
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.057
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.057
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.057
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.057
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.057
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.056
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.056
|
|
|
dna templated transcription elongation
|
GO:0006354 |
13 |
0.055
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.054
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.054
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.054
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.053
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.051
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.051
|
|
|
disaccharide metabolic process
|
GO:0005984 |
1 |
0.050
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.050
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.049
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.049
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.049
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.049
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.049
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.048
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
20 |
0.048
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.047
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.046
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.046
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.046
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.046
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.046
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.045
|
|
|
negative regulation of cellular protein catabolic process
|
GO:1903363 |
22 |
0.045
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.045
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.045
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.044
|
Human |
|
mrna processing
|
GO:0006397 |
63 |
0.043
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.043
|
|
|
negative regulation of neural precursor cell proliferation
|
GO:2000178 |
18 |
0.043
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.043
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.043
|
Human |
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.042
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.042
|
|
|
protein processing
|
GO:0016485 |
163 |
0.041
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.041
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.041
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.041
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.041
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.041
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.041
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.040
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.040
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.039
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.039
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.039
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.038
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.038
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.038
|
Worm |
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.038
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.038
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.037
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.037
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.037
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.037
|
|
|
glial cell fate determination
|
GO:0007403 |
3 |
0.037
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.037
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.037
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.036
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.036
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.035
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.035
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.035
|
|
|
cell growth
|
GO:0016049 |
130 |
0.035
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.034
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.034
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.034
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.034
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.034
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.033
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.033
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.033
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.032
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.032
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.032
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.031
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.031
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.030
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.030
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.030
|
|
|
atp dependent chromatin remodeling
|
GO:0043044 |
9 |
0.030
|
Human |
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.030
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.029
|
Fly |
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.029
|
Human |
|
axonogenesis
|
GO:0007409 |
274 |
0.029
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.029
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.029
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.029
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
37 |
0.029
|
|
|
skin development
|
GO:0043588 |
220 |
0.029
|
Fly |
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.029
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.029
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.028
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.028
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.028
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.028
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.027
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.027
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.027
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.027
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.026
|
|
|
limb development
|
GO:0060173 |
166 |
0.026
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.026
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.026
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.026
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.026
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.026
|
Fly |
|
dna methylation
|
GO:0006306 |
43 |
0.026
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.025
|
|
|
negative regulation of neuroblast proliferation
|
GO:0007406 |
7 |
0.025
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.025
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.025
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.025
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.024
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.024
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.024
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.024
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.024
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.023
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.023
|
Worm |
|
regulation of epidermal growth factor receptor signaling pathway
|
GO:0042058 |
13 |
0.023
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.023
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.023
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.023
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
29 |
0.023
|
Worm |
|
positive regulation of cell fate commitment
|
GO:0010455 |
8 |
0.023
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.023
|
|
|
dna modification
|
GO:0006304 |
50 |
0.022
|
|
|
negative regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032435 |
15 |
0.022
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.022
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.022
|
|
|
base excision repair
|
GO:0006284 |
9 |
0.022
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.022
|
|
|
rna interference
|
GO:0016246 |
2 |
0.022
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.022
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.022
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.022
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.022
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.021
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.021
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.021
|
|
|
gonad development
|
GO:0008406 |
141 |
0.021
|
Worm |
|
oocyte axis specification
|
GO:0007309 |
2 |
0.021
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.021
|
|
|
regionalization
|
GO:0003002 |
337 |
0.021
|
Fly |
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.021
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.021
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.021
|
|
|
tube closure
|
GO:0060606 |
91 |
0.021
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.020
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.020
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.020
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.020
|
Human |
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.020
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.020
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.020
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.020
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.019
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.019
|
|
|
multicellular organismal reproductive behavior
|
GO:0033057 |
23 |
0.019
|
Worm |
|
tissue homeostasis
|
GO:0001894 |
115 |
0.019
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.019
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.019
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.019
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.018
|
|
|
alcohol catabolic process
|
GO:0046164 |
16 |
0.018
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.018
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.018
|
|
|
negative regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903051 |
22 |
0.018
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.018
|
|
|
appendage development
|
GO:0048736 |
166 |
0.018
|
Fly |
|
cellular homeostasis
|
GO:0019725 |
240 |
0.018
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.018
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.018
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.018
|
Human |
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.018
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.018
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.018
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.018
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.017
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.017
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.017
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.017
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.017
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.017
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.017
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.017
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.016
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.016
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.016
|
|
|
pallium development
|
GO:0021543 |
120 |
0.016
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.016
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.016
|
|
|
definitive erythrocyte differentiation
|
GO:0060318 |
7 |
0.016
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.016
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.016
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.016
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.016
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.016
|
Fly |
|
pole plasm assembly
|
GO:0007315 |
2 |
0.016
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.016
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.016
|
|
|
intracellular transport of virus
|
GO:0075733 |
1 |
0.015
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.015
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.015
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.015
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.015
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.015
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.015
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.015
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.015
|
|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.015
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.015
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
18 |
0.015
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.015
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.015
|
|
|
protein localization to chromatin
|
GO:0071168 |
3 |
0.015
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.015
|
Worm |
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.015
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.015
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.015
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.015
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.015
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.014
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.014
|
Worm |
|
attachment of spindle microtubules to kinetochore
|
GO:0008608 |
4 |
0.014
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.014
|
|
|
inner cell mass cell proliferation
|
GO:0001833 |
15 |
0.014
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.014
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.014
|
|
|
mitochondrion transport along microtubule
|
GO:0047497 |
3 |
0.014
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.014
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.014
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.014
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.014
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.014
|
|
|
rna processing
|
GO:0006396 |
105 |
0.013
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.013
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.013
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.013
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.013
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.013
|
|
|
regulation of g2 m transition of mitotic cell cycle
|
GO:0010389 |
10 |
0.013
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.013
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.013
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.013
|
|
|
methylation dependent chromatin silencing
|
GO:0006346 |
6 |
0.013
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.013
|
|
|
negative regulation of stem cell proliferation
|
GO:2000647 |
12 |
0.013
|
|
|
microtubule nucleation
|
GO:0007020 |
2 |
0.013
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.013
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.013
|
|
|
cell division
|
GO:0051301 |
120 |
0.013
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
9 |
0.013
|
|
|
regulation of transcription during mitosis
|
GO:0045896 |
1 |
0.013
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.013
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.013
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.013
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.012
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.012
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.012
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.012
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.012
|
|
|
fertilization
|
GO:0009566 |
127 |
0.012
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.012
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.012
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.012
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.012
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.012
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.012
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.012
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.012
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.012
|
|
|
tube formation
|
GO:0035148 |
140 |
0.012
|
|
|
cation transport
|
GO:0006812 |
399 |
0.012
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.012
|
|
|
trna wobble uridine modification
|
GO:0002098 |
2 |
0.012
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.012
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.012
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.011
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.011
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.011
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.011
|
Worm |
|
regulation of protein complex disassembly
|
GO:0043244 |
28 |
0.011
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.011
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.011
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.011
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.011
|
Worm |
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.011
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.011
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.011
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.011
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.011
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.011
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.011
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.011
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.011
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.011
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.011
|
|
|
positive regulation of reproductive process
|
GO:2000243 |
19 |
0.011
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.011
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.011
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.011
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.011
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.011
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.011
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.010
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.010
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.010
|
|
|
spindle organization
|
GO:0007051 |
28 |
0.010
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.010
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.010
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.010
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.010
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.010
|
|
|
olfactory nerve development
|
GO:0021553 |
3 |
0.010
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.010
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.010
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.010
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.010
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.010
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.010
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.010
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.010
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.010
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.010
|
Fly |
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.010
|
Human |
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.010
|
|